Outside U.S. — Revenue
Eli Lilly Outside U.S. — Revenue increased by 19.7% to $7.68B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 81.2%, from $4.24B to $7.68B. Over 4 years (FY 2021 to FY 2025), Outside U.S. — Revenue shows an upward trend with a 17.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates successful market penetration or growth in international regions, while a decrease may signal competitive pressure, unfavorable currency fluctuations, or regulatory challenges in foreign markets.
Detailed definition
This metric represents the total net sales generated from pharmaceutical products sold in markets outside of the United...
Peer comparison
Peer pharmaceutical companies typically report international revenue as a distinct geographic segment, allowing for comparison of global market share and exposure to ex-US pricing pressures.
lly_segment_non_us_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.04B | $2.78B | $2.82B | $2.64B | $2.55B | $2.52B | $2.64B | $2.52B | $2.78B | $4.13B | $2.90B | $3.07B | $3.47B | $3.63B | $4.50B | $4.24B | $4.74B | $6.30B | $6.41B | $7.68B |
| QoQ Change | — | -8.3% | +1.5% | -6.7% | -3.1% | -1.3% | +4.9% | -4.5% | +10.2% | +48.5% | -29.8% | +6.1% | +12.8% | +4.6% | +24.2% | -5.8% | +11.9% | +32.8% | +1.8% | +19.7% |
| YoY Change | — | — | — | — | -15.9% | -9.5% | -6.4% | -4.2% | +8.9% | +63.9% | +9.6% | +21.8% | +24.7% | -12.2% | +55.3% | +37.9% | +36.8% | +73.8% | +42.5% | +81.2% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Eli Lilly's outside u.s. — revenue?
- Eli Lilly (LLY) reported outside u.s. — revenue of $7.68B in Q1 2026.
- How has Eli Lilly's outside u.s. — revenue changed year-over-year?
- Eli Lilly's outside u.s. — revenue increased by 81.2% year-over-year, from $4.24B to $7.68B.
- What is the long-term trend for Eli Lilly's outside u.s. — revenue?
- Over 4 years (2021 to 2025), Eli Lilly's outside u.s. — revenue has grown at a 17.2% compound annual growth rate (CAGR), from $11.51B to $21.70B.
- What does outside u.s. — revenue mean?
- The total revenue generated from sales of pharmaceutical products in all countries outside of the United States.